Conduit Pharmaceuticals Inc. (CDT) — Capital Reinvestment Ratio

Latest as of June 2026: 0.95x

Conduit Pharmaceuticals Inc. (CDT) has a Capital Reinvestment Ratio of 0.95x as of June 2026, meaning it reinvests 1% of its operating cash flow ($42.74 Million) in capital expenditures ($40.66 Million). Check tangible equity quality of Conduit Pharmaceuticals Inc. to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.95x
Capex / Operating Cash Flow

Operating Cash Flow

$42.74 Million
USD

Capital Expenditures

$40.66 Million
USD

Data as of

Jun 2026
Most recent filing

Annual Capital Reinvestment Ratio for Conduit Pharmaceuticals Inc. (None–None)

Year-by-year Capital Reinvestment Ratio for Conduit Pharmaceuticals Inc. from None to None. See CDT free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow